Health In Tech director Hayes Timothy sold 17,730 shares in two transactions priced from $0.91 to $0.93 per share. After the sales, Timothy held 120,780 shares, giving investors the disclosed post-transaction measure of his remaining position in the company.
Key Highlights
- The transactions took place between 9 September 2026 and 11 September 2026.
- Hayes Timothy’s post-transaction holding was 120,780 shares.
- Both transactions carried SEC transaction code S.
Health In Tech, Inc. (NASDAQ: HIT) director Hayes Timothy sold 17,730 shares in transactions priced from $0.91 to $0.93 per share. The activity involved two separate transactions between 9 September 2026 and 11 September 2026.
Two Transactions Carry SEC Transaction Code S
The filing reported two separate transactions. Each entry carried SEC transaction code S. The prices were stated on a per-share basis, with the reported range extending from $0.91 to $0.93.
That figure is the disclosed holding following these transactions. Transaction code S denotes an open-market or private sale.
FAQs
Q: How many Health In Tech shares did Hayes Timothy sell?
A: Hayes Timothy sold 17,730 Health In Tech shares in two transactions. The reported prices ranged from $0.91 to $0.93 per share.
Q: What was Hayes Timothy’s Health In Tech shareholding after the sale?
A: Hayes Timothy owned 120,780 Health In Tech shares after the transactions. The figure represents his disclosed post-sale holding in the filing.
Q: When did Hayes Timothy sell Health In Tech shares?
A: Hayes Timothy sold Health In Tech, Inc. shares in two separate transactions between 9 September 2026 and 11 September 2026. Both transactions carried SEC transaction code S.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.